Stock et al. (2015) [56] analyzed gelsolin mRNA levels and concluded that high gelsolin levels are associated with a better prognosis in ER(+) HER2(−) breast cancer and a reduction in tumor cell migration. This evidence concerns the gene ERBB2 and neoplasm.